Skip to content
MarketScale
‹ Back to IndustriesHealthcare

A Category Deep Dive on Dialysis

Dialysis is a necessary procedure that allows nearly 500,000 patientsin the United States with kidney failure the opportunity to live normal, productive lives. The treatment removes waste, salt, and extra water when the native kidneys are no longer able. Though there are several types of dialysis, the most common is Hemodialysis, in which blood is removed from the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Dialysis is a necessary procedure that allows nearly 500,000 patientsin the United States with kidney failure the opportunity to live normal, productive lives. The treatment removes waste, salt, and extra water when the native kidneys are no longer able. Though there are several types of dialysis, the most common is Hemodialysis, in which blood is removed from the body, run through a dialyzer, cleaned, and replaced into the body. Dialysis takes three hours to complete and is offered by health systems as inpatient and outpatient treatments.

The federal government pays 80% of all dialysis costs for most patients via Medicare. In fact, the dialysis industry experienced large significant in 1972 when procedures became covered through this program. The industry is run on a for-profit basis, with the market being dominated by two large publicly traded companies known as DaVita and Fresenius. Smaller communities and rural healthcare organizations are more likely to turn to the many local and regional dialysis service providers. Additionally, hospitals or treatment centers must assess the option of operating their own dialysis center for maximum convenience to their patients.

Technology is available to help determine every cost within every purchased services expense category of a health system, revealing massive savings potential in important areas, including dialysis. Here are several factors that healthcare providers should know about dialysis when considering opportunities for savings.

  • The Need for Dialysis is Going Up: The number of patients requiring End Stage Renal Dialysis treatment is increasing each year, with mortality rates depending on the treatment. ESRD, or renal failure, is the fastest-growing cause of hospitalizations, and the fifth leading reason for readmissions.
  • Dialysis Is a Competitive Business. With multiple options usually available for health systems, it’s essential to ensure your organization has evaluated them all recently. Joint ventures between hospitals or health systems and dialysis providers are common. A patient’s choice in healthcare provider and dialysis company are critical factors in driving usage of centers.
  • Savings Opportunities Exist in the Cost of Smaller Purchased Services: Ongoing dialysis treatments can be categorized into purchased services, which is any service contracted and performed by a third party as opposed to the in-house staff at the hospital. Purchased services can account for up to 45% of an average U.S. hospital’s non-labor expenses. However, most health systems continuously tackle savings within the larger categories only, including food, EVS, and blood, ignoring the smaller purchased services categories.
  • Categorize the Entire Spend in a System: Without categorizing their entire purchased services spend and prioritizing opportunities, health systems are missing out on addressing smaller categories—including dialysis—that still have large savings opportunities. Why? Without technology, many systems are not able to categorize their entire organization’s spend and prioritize these kinds of opportunities.

Effective Category Monitoring Helps Health Systems Thrive

By prioritizing opportunities and categorizing purchased service costs, health systems will no longer fail to acknowledge dialysis and other smaller categories. Hospitals and healthcare systems using purchased services expense management technology can identify areas of financial improvement in smaller categories like dialysis by utilizing software that not only identifies but breaks down purchased services and reveals a deeper understanding of the overall costs.

Many Americans require dialysis treatment; however, it is an often-ignored category within purchases services that has potential for great savings. At Valify, we offer a breakthrough technology that uses innovative tools to reveal savings opportunities for each expense, saving hospitals 20-30% per purchased service category, on average.

To discover how our technology platform operates, request a live demo at getvalify.com/demo-valify.

Read more at getvalify.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512